Innoviva, Inc. (INVA) stock
INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3039% below fair value
$18.40+0.10 (+0.55%)
Close on Nov 18, 2026Market cap $1.33BP/E 9.3Yield –
Innoviva net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for Innoviva
Innoviva has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?